The latest
Blogs
How AI-driven patient engagement platforms are transforming pharma marketing in 2026
Preparing for an AI-first future in life sciences
AI in Australian pharmaceutical marketing: opportunities, risks and readiness
Managing risk in AI adoption
The reality of AI in Australia
Pharma’s digital delay is costing patients outcome
The opportunities for AI in pharma marketing
AI-powered pharma sales enablement guide 2026
AI in healthcare Australia: why doing nothing is the Biggest Risk
The new way of working: from static campaigns to dynamic conversations
Human readiness: The Key to unlocking AI’s potential
You have invested in AI for clinical trials. What about commercialization?
From awareness to action: How RoseRx helps patients find the right care, faster
Why RoseRx is leading the Australian pharma digital-engagement revolution in 2026
Agentic AI in pharma: Redefining patient engagement and HCP engagement
Top engagement & pharma trends shaping 2026
RoseRx strengthens AI-first strategy and global expansion with senior leadership appointments
Why the next best action is the only thing that matters
RoseRx launches “future pharma”, a podcast exploring AI innovation and technology in life sciences
Rethinking ROI: How AI re-defines value in healthcare communication and operations
Compliance teams the surprise leaders in pharma’s AI transformation towards hyper-personalization and engagement
AI and the new era of pharma: 3 focus areas that stand out
How generative AI is transforming pharma marketing
Patient engagement: How effective is your digital awareness campaign?
How to scale HCP engagement without the cost & disruption
How pharma's direct-to-consumer shift is transforming healthcare
Blogs
How AI is revolutionizing the pharmaceutical sales rep role
How AI-driven patient engagement platforms are transforming pharma marketing in 2026
Preparing for an AI-first future in life sciences
AI in Australian pharmaceutical marketing: opportunities, risks and readiness
Managing risk in AI adoption
The reality of AI in Australia
Pharma’s digital delay is costing patients outcome
The opportunities for AI in pharma marketing
AI-powered pharma sales enablement guide 2026
AI in healthcare Australia: why doing nothing is the Biggest Risk
Podcasts
From crawl to run: The reality of AI implementation in pharma with Arthur Alston (Coming soon)
Leading with empathy, with David Henderson at Takeda (Coming soon)
Pharma's AI Opportunity with AJ Rollsy at HealthPoint Research
AI, privacy and the red line in healthcare with Phil O'Sullivan at Allens
